These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10823749)

  • 21. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
    Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U
    Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quasispecies of hepatitis C virus in serum and in three different parts of the liver of patients with chronic hepatitis.
    Sakai A; Kaneko S; Honda M; Matsushita E; Kobayashi K
    Hepatology; 1999 Aug; 30(2):556-61. PubMed ID: 10421668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replication of hepatitis C virus in ascitic mononuclear cells with development of distinct viral quasispecies.
    Hsu CW; Yeh CT; Chen PG; Liaw YF
    J Infect Dis; 1999 Oct; 180(4):992-1000. PubMed ID: 10479123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
    Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
    J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
    Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
    J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of response to treatment in chronic hepatitis C].
    Leroy V; Hilleret MN
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B23-31. PubMed ID: 12180294
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term follow-up study of sustained biochemical responders with interferon therapy.
    Shindo M; Hamada K; Oda Y; Okuno T
    Hepatology; 2001 May; 33(5):1299-302. PubMed ID: 11343259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up.
    Hiraga N; Suzuki F; Akuta N; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Watabiki S; Satoh J; Kumada H
    J Med Virol; 2005 Feb; 75(2):240-8. PubMed ID: 15602722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels.
    Sookoian S; Castaño G; Frider B; Flichman D
    Medicina (B Aires); 2002; 62(3):226-30. PubMed ID: 12150004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of HCV-RNA in liver tissue does not correlate with inflammatory process and fibrosis activity in chronic hepatitis C].
    Bielawski KP; Lakomy EA; Witczak-Malinowska K; Michalska Z; Falkiewicz B
    Med Dosw Mikrobiol; 2004; 56(4):405-9. PubMed ID: 15959997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of hepatitis C viral genome associated with disease progression.
    Nagayama K; Kurosaki M; Enomoto N; Miyasaka Y; Marumo F; Sato C
    Hepatology; 2000 Mar; 31(3):745-50. PubMed ID: 10706567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.
    Pessione F; Degos F; Marcellin P; Duchatelle V; Njapoum C; Martinot-Peignoux M; Degott C; Valla D; Erlinger S; Rueff B
    Hepatology; 1998 Jun; 27(6):1717-22. PubMed ID: 9620348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease.
    Honda M; Kaneko S; Sakai A; Unoura M; Murakami S; Kobayashi K
    Hepatology; 1994 Nov; 20(5):1144-51. PubMed ID: 7927245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity?
    Pontisso P; Bellati G; Brunetto M; Chemello L; Colloredo G; Di Stefano R; Nicoletti M; Rumi MG; Ruvoletto MG; Soffredini R; Valenza LM; Colucci G
    Hepatology; 1999 Feb; 29(2):585-9. PubMed ID: 9918939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels.
    Calabrese F; Pontisso P; Pettenazzo E; Benvegnù L; Vario A; Chemello L; Alberti A; Valente M
    Hepatology; 2000 May; 31(5):1153-9. PubMed ID: 10796892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation.
    Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W
    Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.